Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06571084 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

New Screening and Diagnostic Cut-off Points of PA Patients

StatusUnknown
PhaseNot specified
Started2024-01-04
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 26, 2024 (before its estimated October 2024 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
minor
Trial status changed: Recruiting → Unknown
This study aims to establish the screening and diagnostic cut-off points for primary aldosteronism patients by a novel small molecule "sandwich method" aldosterone and renin chemiluminescent immunoassay.
Trial Details
NCT Number NCT06571084
Lead Sponsor China National Center for Cardiovascular Diseases
Collaborators: Beijing Anzhen Hospital, First Affiliated Hospital of Chongqing Medical University, Chinese Academy of Medical Sciences, Fuwai Hospital, Wuhan Asia Heart Hospital
Conditions Primary Aldosteronism
Enrollment 770 participants
Start Date 2024-01-04
Primary Completion 2024-10 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-26